Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    VAL--083
Show Display Options
Rank Status Study
1 Recruiting Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor
Conditions: Glioma;   Glioblastoma;   Glioblastoma Multiforme;   GBM;   Brain Cancer
Intervention: Drug: VAL-083
2 Completed A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: Platinum-based chemotherapy
3 Completed Long-term Study of Cariprazine in Patients With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Cariprazine
4 Unknown  Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients
Condition: Hypertension
Intervention: Drug: lacidipine (4 mg) or losartan (50 mg)
5 Completed
Has Results
Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
Condition: Irritable Bowel Syndrome Characterized by Constipation
Interventions: Drug: Linaclotide 290 micrograms;   Drug: Matching placebo

Indicates status has not been verified in more than two years